False-positive buprenorphine EIA urine toxicology results due to high dose morphine

A case report

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In monitoring a patient with chronic pain who was taking high-dose morphine and oxycodone with weekly urine enzymatic immunoassay (EIA) toxicology testing, the authors noted consistent positives for buprenorphine. The patient was not taking buprenorphine, and gas chromatography/mass spectroscopy (GCMS) testing on multiple samples revealed no buprenorphine, indicating a case of false-positive buprenorphine EIAs in a high-dose opiate case. The authors discontinued oxycodone for a period of time and then discontinued morphine. Urine monitoring with EIAs and GCMS revealed false-positive buprenorphine EIAs, which remained only when the patient was taking morphine. When taking only oxycodone and no morphine, urine samples became buprenorphine negative. When morphine was reintroduced, false-positive buprenorphine results resumed. Medical practitioners should be aware that high-dose morphine (with morphine urine levels turning positive within the15,000 to 28,000 mg/mL range) may produce false-positive buprenorphine EIAs with standard urine EIA toxicology testing.

Original languageEnglish (US)
Pages (from-to)329-331
Number of pages3
JournalJournal of Addictive Diseases
Volume31
Issue number4
DOIs
StatePublished - Oct 1 2012

Fingerprint

Buprenorphine
Immunoassay
Toxicology
Morphine
Urine
Oxycodone
Gas Chromatography
Opiate Alkaloids
Mass Spectrometry
Physiologic Monitoring
Chronic Pain

Keywords

  • Buprenorphine
  • enzymatic immunoassay
  • false-positive buprenorphine
  • morphine
  • oxycodone

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

False-positive buprenorphine EIA urine toxicology results due to high dose morphine : A case report. / Tenore, Peter L.

In: Journal of Addictive Diseases, Vol. 31, No. 4, 01.10.2012, p. 329-331.

Research output: Contribution to journalArticle

@article{15137a64d35c42ddae2b5530f44a9b27,
title = "False-positive buprenorphine EIA urine toxicology results due to high dose morphine: A case report",
abstract = "In monitoring a patient with chronic pain who was taking high-dose morphine and oxycodone with weekly urine enzymatic immunoassay (EIA) toxicology testing, the authors noted consistent positives for buprenorphine. The patient was not taking buprenorphine, and gas chromatography/mass spectroscopy (GCMS) testing on multiple samples revealed no buprenorphine, indicating a case of false-positive buprenorphine EIAs in a high-dose opiate case. The authors discontinued oxycodone for a period of time and then discontinued morphine. Urine monitoring with EIAs and GCMS revealed false-positive buprenorphine EIAs, which remained only when the patient was taking morphine. When taking only oxycodone and no morphine, urine samples became buprenorphine negative. When morphine was reintroduced, false-positive buprenorphine results resumed. Medical practitioners should be aware that high-dose morphine (with morphine urine levels turning positive within the15,000 to 28,000 mg/mL range) may produce false-positive buprenorphine EIAs with standard urine EIA toxicology testing.",
keywords = "Buprenorphine, enzymatic immunoassay, false-positive buprenorphine, morphine, oxycodone",
author = "Tenore, {Peter L.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1080/10550887.2012.735598",
language = "English (US)",
volume = "31",
pages = "329--331",
journal = "Journal of Addictive Diseases",
issn = "1055-0887",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - False-positive buprenorphine EIA urine toxicology results due to high dose morphine

T2 - A case report

AU - Tenore, Peter L.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - In monitoring a patient with chronic pain who was taking high-dose morphine and oxycodone with weekly urine enzymatic immunoassay (EIA) toxicology testing, the authors noted consistent positives for buprenorphine. The patient was not taking buprenorphine, and gas chromatography/mass spectroscopy (GCMS) testing on multiple samples revealed no buprenorphine, indicating a case of false-positive buprenorphine EIAs in a high-dose opiate case. The authors discontinued oxycodone for a period of time and then discontinued morphine. Urine monitoring with EIAs and GCMS revealed false-positive buprenorphine EIAs, which remained only when the patient was taking morphine. When taking only oxycodone and no morphine, urine samples became buprenorphine negative. When morphine was reintroduced, false-positive buprenorphine results resumed. Medical practitioners should be aware that high-dose morphine (with morphine urine levels turning positive within the15,000 to 28,000 mg/mL range) may produce false-positive buprenorphine EIAs with standard urine EIA toxicology testing.

AB - In monitoring a patient with chronic pain who was taking high-dose morphine and oxycodone with weekly urine enzymatic immunoassay (EIA) toxicology testing, the authors noted consistent positives for buprenorphine. The patient was not taking buprenorphine, and gas chromatography/mass spectroscopy (GCMS) testing on multiple samples revealed no buprenorphine, indicating a case of false-positive buprenorphine EIAs in a high-dose opiate case. The authors discontinued oxycodone for a period of time and then discontinued morphine. Urine monitoring with EIAs and GCMS revealed false-positive buprenorphine EIAs, which remained only when the patient was taking morphine. When taking only oxycodone and no morphine, urine samples became buprenorphine negative. When morphine was reintroduced, false-positive buprenorphine results resumed. Medical practitioners should be aware that high-dose morphine (with morphine urine levels turning positive within the15,000 to 28,000 mg/mL range) may produce false-positive buprenorphine EIAs with standard urine EIA toxicology testing.

KW - Buprenorphine

KW - enzymatic immunoassay

KW - false-positive buprenorphine

KW - morphine

KW - oxycodone

UR - http://www.scopus.com/inward/record.url?scp=84871984000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871984000&partnerID=8YFLogxK

U2 - 10.1080/10550887.2012.735598

DO - 10.1080/10550887.2012.735598

M3 - Article

VL - 31

SP - 329

EP - 331

JO - Journal of Addictive Diseases

JF - Journal of Addictive Diseases

SN - 1055-0887

IS - 4

ER -